Keywords: درمان های هدفمند; antiangiogenics; chemotherapy; epithelial ovarian cancer; PARP inhibitors; targeted therapeutics;
مقالات ISI درمان های هدفمند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان های هدفمند; Protein glycosylation; Gastric cancer; Colorectal cancer; Targeted therapeutics; Glycoprotomics; Cancer glycans;
Keywords: درمان های هدفمند; Cell targeting peptides; Targeted nano-carriers; Targeted therapeutics; Targeted diagnostic agents;
Keywords: درمان های هدفمند; Cancer; Targeted therapeutics; Antibody–drug conjugates (ADCs); Adcetris; Antibody–drug ratio (ADR); Monoclonal antibodies (mAbs); Kadcyla; Linker; Multidrug resistance (MDR); Mylotarg
Keywords: درمان های هدفمند; Folate; Folate receptor; Endocytosis; Cancer; Targeted therapeutics; Small molecule drug conjugates; Personalized medicine;
Keywords: درمان های هدفمند; Cytotoxic cancer drugs; Antineoplastic drugs; Selective oncology drugs; Targeted therapeutics; Functional definition; Occupational health; Pharmaceutical manufacturing; Drug development;
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Keywords: درمان های هدفمند; TP53; Drug sensitivity; Targeted therapeutics; Signal transduction inhibitors;
EditorialJak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
Keywords: درمان های هدفمند; Jak stat signaling in cancer; Targeted therapeutics; Tumor microenvironment; Immune therapy; Signaling pathway interactions;
ReviewClinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer
Keywords: درمان های هدفمند; Clinical trials; Insulin-like growth factor (IGF); IGF-IR inhibitors; Monoclonal antibody; Targeted therapeutics; Tyrosine kinase inhibitors;
Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas
Keywords: درمان های هدفمند; Glioblastoma; Invasive malignant glioma; Biodegradable nanoparticles; Targeted therapeutics; Fibroblast growth factor-inducible 14; Multiple particle tracking; Surface plasmon resonance;
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: Design, synthesis and evaluation
Keywords: درمان های هدفمند; MCR; RET; Medicinal chemistry; Lead discovery; Targeted therapeutics; KinaseRET, rearranged during transfection; MTC, medullary thyroid cancer; VEGFR-2, vascular endothelial growth factor receptor 2; MCR, multicomponent reaction; SAR, structure activity r
Pharmaceutical NanotechnologyFolate-functionalized nanoparticles for controlled ergosta-4,6,8(14),22-tetraen-3-one delivery
Keywords: درمان های هدفمند; Ergosta-4,6,8(14),22-tetraen-3-one (ergone); Nanoparticles; Folate receptor; Targeted therapeutics; Slow release capacity; Anticancer;
Design and conduct of early-phase radiotherapy trials with targeted therapeutics: Lessons from the PRAVO experience
Keywords: درمان های هدفمند; Radiotherapy; Targeted therapeutics; Study design; Histone deacetylase inhibitor;
The follicle-stimulating hormone receptor: A novel target in genitourinary malignancies
Keywords: درمان های هدفمند; Follicle-stimulating hormone receptor; Targeted therapeutics; Neoangiogenesis
Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate
Keywords: درمان های هدفمند; Rhaponticin (RHA); Folate receptor; Targeted therapeutics; Anticancer; Toxicity
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
Keywords: درمان های هدفمند; Lapatinib; Teratoid Rhabdoid tumors; Targeted therapeutics
Regioselective synthesis and initial evaluation of a folate receptor targeted rhaponticin prodrug
Keywords: درمان های هدفمند; Rhaponticin (RHA); Targeted therapeutics; Folate; Prodrug; Anticancer
Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo
Keywords: درمان های هدفمند; Targeted therapeutics; Antioxidant therapy; Liposomes; NOX2 inhibition; Endothelial targeting; Inflammation
Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer
Keywords: درمان های هدفمند; Ovarian carcinoma; genetics; epigenetic; targeted therapeutics; BRCA1; EGFR; PI3K
Management of non-small-cell lung cancer in the older adult
Keywords: درمان های هدفمند; Lung cancer; Geriatric oncology; Geriatric assessment; Targeted therapeutics; Combination chemotherapy; Supportive care;
Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy
Keywords: درمان های هدفمند; Magnetic resonance spectroscopy; Choline; Glycolysis; Targeted therapeutics; Biomarkers;
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
Keywords: درمان های هدفمند; DNA; Aptamer; Nanomaterials; Diagnostics; Biosensor; Drug delivery; Biomedical; Targeted therapeutics
Complex prolactin crosstalk in breast cancer: New therapeutic implications
Keywords: درمان های هدفمند; Prolactin; Breast cancer; Signaling crosstalk; Targeted therapeutics
Nanoparticles in cellular drug delivery
Keywords: درمان های هدفمند; Nanomaterials; Nanoparticles; Drug delivery; Targeted therapeutics
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides
Keywords: درمان های هدفمند; Tubulysin; Targeted therapeutics; Folate; Anti-cancer; Disulfide
Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide
Keywords: درمان های هدفمند; Desacetylvinblastine; Targeted therapeutics; Folate; Disulfide; Anti-cancer
La place des thérapeutiques ciblées dans la prise en charge des CBNPC
Keywords: درمان های هدفمند; Thérapeutiques ciblées; Facteurs de croissance; Récepteur tyrosine-kinase; Signalisation intracellulaire; EGF-R; Ras; VEGF; ERCC1; Targeted therapeutics; Growth factors; Tyrosine-kinase receptors; Cell signaling; EGF-R; Ras; VEGF; ERCC1;